【レポートの概要(一部)】
1. Executive Summary
1.1 Sector Highlights
1.2 Aim, Scope and Format of This Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Relating to the Report
2. Introduction to Needle-Free Delivery of Drugs/Vaccines
2.1 What is Needle-Free Technology?
2.1.1 History of Needle-Free Injections (NFI)
2.2 Why the Need For Needle-Free Delivery Technology?
2.2.1 Needle Stick Injury
2.2.1.1 Blood-Borne Pathogens and Needle Stick Injury
2.2.1.2 Accidental Needle Stick Injury: A Serious Healthcare Problem
2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
2.3.1 Pain Management
2.3.1.1 Pain Management: Using NFI Devices to Administer Lidocaine
2.3.2 Vaccine Delivery: Improving Immune Response
2.3.2.1 The Global Vaccine Market, 2014-2024
2.3.2.2 Needle-Free Vaccine Delivery
2.3.2.3 Mass Immunisation
2.3.3 Insulin Delivery For Diabetics
2.3.4 Paediatric Injections
2.3.5 Other Uses For Needle-Free Injection Technology
2.4 Advantages and Disadvantages of Needle-Free Injections
2.5 The Needle-Free Delivery Market
2.5.1 Jet Injectors
2.5.1.1 Concerns About Multi-use Nozzle Jet injectors (MUNJIs)
2.5.1.2 Strengths and Weaknesses of Jet Injectors
2.5.2 Competing Needle-Free Technologies
2.5.2.1 Novel Needle Technology
2.5.2.1.1 Pen Needles
2.5.2.1.2 Microneedles
2.5.2.1.3 Hollow Microneedles
2.5.2.1.4 Solid Coated Microneedles
2.5.2.1.5 Solid Biodegradable Microneedles
2.5.2.1.6 Solid Uncoated Microneedles
2.5.2.1.7 Selection of Microneedles
2.5.2.2 Inhaler Technology
2.5.2.3 Transdermal Patch Technology
2.6 Regulation of the Needle-Free Delivery Market
2.6.1 The US Regulation System
2.6.1.1 Combination Products
2.6.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-approved Needle-Free Devices
2.6.2 The European Regulation System
2.6.2.1 Post Marketing Surveillance in the EU
3. The Global Needle-Free Injection Device Market, 2014-2024
3.1 The Needle-Free Delivery Technology Market: Overview
3.2 The Needle-Free Delivery Technology Market by Segments, 2012-2013
3.3 The Needle-Free Delivery Market Forecast, 2014-2024
3.4 Needle-Free Delivery Technology: Market Trends, 2014-2024
4. The Jet Injectors Technology Market, 2014-2024
4.1 The Jet Injectors Market, 2012-2013
4.2 The Jet Injectors Market Forecast, 2014-2024
4.3 Leading Devices in the Jet Injectors Market, 2014
4.3.1 Biojector 2000 (Bioject Medical Technologies)
4.3.2 SUMAVEL DosePro (Zogenix)
4.3.3 E-Jet 100 (Eurojet Medical)
4.3.4 STRATIS (Pharmajet)
4.3.5 ZetaJet (Bioject Medical Technologies)
4.3.6 LectraJet (D’Antonio Consultants International)
4.3.7 Med-Jet (Medical International Technologies)
4.3.8 Vision (Antares Pharma)
4.3.9 Glide System (Glide Pharmaceutical Technologies)
4.3.10 AdvantaJet (Activa Brand Products)
4.3.11 J-Tip (National Medical Products)
4.3.12 SQ-Pen (Diabetes Management International)
4.3.13 Vitajet3 (Bioject Medical Technologies)
4.3.14 Penjet (Penjet Corporation)
4.3.15 INJEX30 (Injex)
4.4 Jet Injectors Development Pipeline, 2014
4.4.1 Zeneo (Crossject Medical Technologies)
4.4.2 Jupiter Jet (Bioject Medical Technologies)
4.4.3 Iject (Bioject Medical Technologies)
4.4.3.1 Iject R (Bioject Medical Technologies)
4.4.4 Relday (Zogenix)
4.5 Concluding Remarks
5. Competing Needle-Free Technology Market, 2014-2024
5.1 Competing Needle-Free Technologies: Overview
5.2 Competing Needle-Free Technology Market, 2012-2013
5.3 Competing Needle Free Technologies Market Forecast by Segments, 2014-2024
5.4 Novel Needle Technology Market, 2013
5.4.1 Novel Needle Technology Market Forecast, 2014-2024
5.4.2 Leading Products in the Microneedle Technology Market, 2014
5.4.3 Microneedle Patches for Vaccine Delivery, 2014
5.4.3.1 Microneedle Patch for the Polio Vaccine (Georgia Tech’s School of
Chemical and Biomolecular Engineering)
5.4.3.2 AdminPen (nanoBioSciences)
5.4.3.3 PKA SoftTouch (PKA SoftTouch Corp)
5.4.3.4 DrugMAT (TheraJect)
5.4.3.5 MicroCor (Corium International)
5.4.3.6 Nanopatch (Vaxxas)
5.4.3.7 ZP Patch Technology (Zosana)
5.5 Inhaler Technology Market, 2013
5.5.1 Inhaler Technology Market Forecast, 2014-2024
5.5.2 Inhalers in the Asthma Market, 2014
5.5.3 Inhalers in the Insulin Market, 2014
5.5.4 Inhalers in the Vaccine Market, 2014
5.6 The Patch Technology Market, 2013
5.6.1 The Patch Technology Market Forecast, 2014-2024
5.6.2 Drug Patches in the Market, 2014
5.7 Other Competing Needle-free delivery Technology in development
5.7.1 Magnetic Injection
5.7.2 Laser Injection
5.7.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
5.7.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South
Korea)
5.7.5 Nanotechnology Implant (University of California, San Francisco)
6. Leading National Needle-Free Delivery Markets, 2014-2024
6.1 Leading National Breakdown of the Needle-Free Delivery Market, 2012-2013
6.2 The Leading National Needle-Free Delivery Market Forecast, 2014-2024
6.3 The US Needle-Free Delivery Market Forecast, 2014-2024
6.4 The European Needle-Free Delivery Market, 2013
6.4.1 The European Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.1 The German Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.2 The French Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.3 The Italian Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.4 The Spanish Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.5 The UK Needle-Free Delivery Market Forecast, 2014-2024
6.5 The Japanese Needle-Free Delivery Market Forecast, 2014-2024
6.6 The Chinese Needle-Free Delivery Market Forecast, 2014-2024
6.7 The Indian Needle-Free Delivery Market Forecast, 2014-2024
7. Leading Companies in the Needle-Free Delivery Market 2014
7.1 Antares Pharma
7.1.1 Sales and Performance Analysis
7.1.2 Product Sales, 2012
7.1.3 Revenue by Region, 2012
7.1.4 Revenue by Major Customers, 2011-2012
7.1.5 Sales and Performance Analysis, 3Q 2013
7.1.6 Technology of Antares Pharma
7.1.6.1 Pressure Assisted Injection Devices
7.1.6.2 Transdermal Gel System
7.1.7 Marketed Products, 2014
7.1.8 Pipeline Products, 2014
7.2 Zogenix
7.2.1 Sales and Performance Analysis
7.2.2 Sales by Segment, 2013
7.2.3 Needle-Free Products
7.2.3.1 Marketed Products, 2014
7.2.3.1.1 Sumavel® DosePro®: Rapid Acting Migraine Relief
7.2.3.1.2 Zohydro™ ER (hydrocodone bitartrate) Extended-Release Capsules
7.2.3.1.3 Zohydro™ ER Approval: Cause for Controversy?
7.2.3.1.4 Pipeline Products, 2014
7.2.4 Collaborations
7.2.4.1 Co-promotion of Migranal Nasal Spray with Valeant
7.2.5 Manufacturing
7.3 Bioject Medical Technologies
7.3.1 Sales and Performance Analysis
7.3.2 Sales Performance Analysis by Products
7.3.3 Sales and Performance Analysis, 3Q 2012-2013
7.3.4 Bioject’s Sales Revenue Setbacks
7.3.5 Collaborations
7.3.5.1 Navy Malaria Study: Utilises Bioject’s B2000 Technology
7.3.5.2 Cyto Pulse Sciences: Clinical Trials for an HIV/DNA vaccine
7.3.5.3 CDA intradermal influenza study
7.3.5.4 MPI Research: Seeking Drug/Device Combinations
7.3.5.5 World Health Organisation (WHO): The Push to Eradicate Infectious Disease in Developing Countries
7.3.6 Needle-Free Products
7.3.6.1 Biojector® 2000: Adaptable Power Source Allows Use in Home and Mass Vaccination Setting
7.3.6.2 Vitajet™: Low-cost Insulin Delivery System
7.3.6.3 ZetaJet™: Auto-disable Feature Improves User Safety
7.3.7 Needle-Free Injection Device Pipeline
7.3.7.1 Intradermal Pen Injector: Targeted Drug Delivery
7.3.7.2 Iject®: Providing Tailored Depth of Penetration
7.3.7.3 Jupiter Jet: Multi Dosing With Single Loaded Syringe
7.4 3M
7.4.1 Sales and Performance Analysis
7.4.2 3M Drug Delivery Systems
7.4.2.1 Inhalation
7.4.2.2 Transdermal patch
7.4.2.3 Microneedles
7.5 Medical International Technology (MIT)
7.5.1 Sales and Performance Analysis
7.5.2 Increased Product Awareness Through Globalisation
7.5.2.1 Further Expansion in China
7.5.3 Products
7.5.3.1 Med Jet
7.6 D’Antonio Consultants International (DCI)
7.6.1 Needle-Free Products
7.6.1.1 LectraJet®: Lightweight Device Reduces User Fatigue
7.6.2 Needle-Free Injection Device Pipeline
7.6.2.1 Low Workload Jet Injector: Single-shot Manual System
7.6.2.2 Multi Channel Jet Injector: For Simultaneous Vaccine Delivery
7.7 PharmaJet
7.7.1 Needle-Free Products
7.7.1.1 STRATIS®: Drug Delivery in Less Than a Second
7.7.1.2 Applications
7.7.2 Collaborations: Pursuing a Drug/Device Combination for Vaccine Administration
7.8 Akra Dermojet
7.8.1 Needle-Free Products
7.8.1.1 DERMOJET® “HR”: User-Friendly Design Allows Use in High Intensive Applications
7.8.1.2 DERMOJET Polymedical®: Interchangeable Injection Tips Reduces Risk of Contamination
7.8.1.3 Automatic DERMOJET®
7.9 Injex Pharma
7.9.1 Injex 30
7.9.1.1 Injex 30’s Applications
7.9.2 Injex’s Worldwide Distribution
7.9.2.1 Exclusive Distributor Agreement with Russia’s Medici Ltd.
7.9.2.2 Chinese SFDA approval
7.9.2.3 NHS’s Withdrawal of Injex30
7.10 Glide Pharma
7.10.1 Applications
7.10.1.1 Glide SDI system’s Advantages
7.10.2 Injecting Solid Formulations
7.10.3 Pharmaceutical Companies
7.10.4 Collaboration with Pfenex Inc. to Aid Delivery of Solid Dose Vaccine
8. Qualitative Analysis of the Needle-Free Delivery Market, 2014-2024
8.1 SWOT Analysis of the Needle-Free Delivery Market, 2014-2024
8.2 Strengths
8.2.1 Strong Growth in the Biologic Drug Market
8.2.2 Increasing Development in Transdermal Delivery
8.2.3 No Specialist Training Required for Drug/Vaccine Delivery
8.2.4 Eliminating the Cold Chain Problem
8.2.5 Reduction in Needle Stick Injuries
8.3 Weaknesses
8.3.1 Healthcare Practitioners are not Familiar with Novel Delivery Systems
8.3.2 Current Inefficient Manufacturing Processes Lead to Costly Needle-Free
Technology
8.3.3 Current Technology is Very Expensive
8.4 Opportunities
8.4.1 Emerging Economies Offer Significant Growth Opportunities
8.4.2 Mass Immunisation Programs Around the World
8.4.3 Increasing Global Diabetes Population
8.4.4 Shift Towards Home Administration Setting
8.4.5 Extending Life Cycle of Drugs
8.5 Threats
8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
8.5.1.1 Needle and Syringes with Anti Needle-Stick Injury Technology
8.5.2 Greater Regulatory Scrutiny
8.5.3 Limited Clinical Data
8.5.4 Medical Device Excise Tax
9. Expert Opinion
9.1 Interview with Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor,
Department of Chemistry and Biochemistry Center for Pharmaceutical Biotechnology, University of Colorado, Boulder
9.1.1 Aktiv-Dry’s PuffHaler
9.1.2 The Benefits of Inhaler Technology
9.1.3 The Competitive Landscape for Measles Inhaler Vaccines
9.1.4 ACTIV DRY’S Collaborations
9.1.5 The Challenges to Introduction Novel Inhaler Technology
9.2 Interview with David Hoey, CEO, Vaxxas
9.2.1 Vaxxas’s Nanopatch™ technology
9.2.2 The Advantages of Using Nanopatch Technology in Developed and Developing
Markets
9.2.3 The Challenges of Manufacturing Patch Technology
9.2.4 The Future for the Nanopatch Technology
9.3 Professor Mark Kendall, Inventor of the Nanopatch and Co-founder of Vaxxas
9.3.1 Microneedles: Proof of Concept to Commerical Product
9.3.2 Needle Delivery Market is Still Strong
9.3.3 The Microneedle Market
9.4 Interview with John Turanin, Vice President and General Manager, Zogenix Technologies
9.4.1 The Use of Gas Power in Jet Injectors
9.4.2 The Incentives for Drug Companies in Adopting Needle-Free Delivery
9.4.3 Regulating the Needle-Free Delivery Technology Market
9.4.4 Regional Market Forecasts for Jet Injectors
9.4.5 Jet Injectors: Competitive Space and Restraints on the Market
9.4.6 Regional Market Forecasts for Jet Injectors
9.4.7 Jet Injectors: Competitive Space and Restraints on the Market
9.5 Interview with Mark Logomasini, President and CEO, Bioject Medical Technologies
9.5.1 The Spring-Powered, Gas-Powered and Battery Powered Jet Injector Markets
9.5.2 Other Competing Needle-Free Delivery Platforms
9.5.3 Regulations Determine Jet Injector Market
9.5.4 Small Needle Free Delivery Companies Requires Large External Capital
10. Conclusions
10.1 The Needle-Free Delivery Market, 2014-2024
10.2 Transdermal Delivery For Vaccine Delivery
10.3 Biologic Drugs are a Major Driver of the Needle Free Delivery Market
10.4 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market
10.5 Concluding Remarks
【レポート販売概要】
■ タイトル:ニードルフリー(無針)ドラッグデリバリー市場(2014-2024)■ 英文:Needle-Free Delivery: Technology and Market Forecast 2014-2024
■ 発行日:2014年4月
■ 調査会社:visiongain
■ 商品コード:Visiongain-405312
■ 調査対象地域:グローバル
- 凍結治療の世界市場予測(~2024年)“The cryotherapy market is projected to grow at a CAGR of 9.1% during the forecast period.” The cryotherapy market is projected to reach USD 319 million by 2024 from USD 206 million in 2019 at a CAGR of 9.1%. The rising incidence of sports injuries, cardiac conditions, and cancers is driving the growth of the market. Increasing demand for minimally invasive procedures, technological advancements i …
- Diabetic Peripheral Neuropathy:治療薬のグローバル治験動向(2014年上半期)Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Peripheral Neuropathy. It includes an o …
- 中小企業(SME)ビックデータ管理のグローバル市場動向(2014-2018)About SME Big Data Big data solutions include a wide range of hardware, software, and services required for processing and analyzing structured and unstructured data that is too big for traditional data processing tools to manage. These data are generated by various sources such as mobile devices, digital repositories, and enterprise applications and range in size from terabytes (10^12 bytes) to p …
- 熱可塑性樹脂の微細成形の世界市場:用途別(テレコム用光ファイバー、医療・ヘルスケア、マイクロドライブシステム・コントロール、自動車産業、その他)、地域別予測Global Thermoplastic Micro Molding Market to reach USD XXX billion by 2025. Global Thermoplastic Micro Molding Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets are rising infrastructure spending and growing automotive demand, remarkably high n …
- クリティカル電源・冷却ソリューションの世界市場予測(~2021):電源ソリューション(UPS、発電機)、冷却ソリューション(エアコン、チラー、冷却タワー、液冷システム)The critical power and cooling market is projected to grow at a CAGR of 8.88%, from 2016 to 2021, to reach USD 25.80 Billion by 2021. A rise in digitalization and cloud computing leading to an increase in demand for data centers, increasing demand for improved cooling efficiency in data centers, a need to reduce anomalies in power supply, and regulations and initiatives by institutes and associati …
- 世界のポリエステルフィラメント糸市場2015The Global Polyester Filament Yarns Industry Report 2015 is a professional and in-depth study on the current state of the Polyester Filament Yarns industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Polyester Filament Yarns market analysis is provided for the international markets including development …
- ITSM(ITサービスマネジメント)の世界市場2016-2020About Information Technology Service Management ITSM is a process that adopts and implements IT tools to deliver top-quality IT services in an organization. These tools are provided through people, processes, and technologies. ITSM delivers end-to-end services using best practice models, instead of managing each IT component separately. Technavio’s analysts forecast the global information technolo …
- 分子細胞遺伝学の世界市場分析:技術別(FISHおよびCGH)、用途別(遺伝的疾患、がん、オーダメイド医療)、セグメント予測Global molecular cytogenetics market is expected to reach nearly USD 3.6 billion by 2022, according to a new report by Grand View Research, Inc. Increasing instances of both, chromosomal anomalies implicated in genetic disorders and cancer, coupled with technological advancements in the molecular cytogenetic techniques is expected to positively reinforce the market growth. Technological advancemen …
- 世界のSAN市場動向(2012-2016)TechNavio's analysts forecast the Global Storage Area Networks (SAN) market to grow at a CAGR of 8.42 percent over the period 2012-2016. One of the key factors contributing to this market is the improved scalability facilitated by SAN solutions. The Global SAN market has also been witnessing an increasing adoption of Fiber Channel over Ethernet (FCoE) solutions. However, high cost of FC SAN soluti …
- CCTVカメラの世界市場:アナログ/デジタルCCTVカメラ、DVR、NVR、IP監視カメラAbout Closed Circuit Television CCTVs are video cameras that are used for video surveillance by transmitting signals from a specific place to another. The signals are not openly broadcasted, instead they are restricted to be monitored by only a set of people located in a particular place. CCTV cameras have wide usage worldwide by government enterprises to combat and avoid domestic as well as inter …
- 世界のMake-up市場におけるM&A動向(2014年2月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global make-up market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global make-up market throughout the month. Additionally, the report provides an overview of all the partner …
- 世界のトップ10ホテル運営企業分析Summary The Travel and Tourism Intelligence Center Global Top 10 Hotel Operators Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global hotel operators industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Marriott Intern …
- バイオセンサーの世界市場:電気化学型バイオセンサー、圧電型バイオセンサー、光型バイオセンサー、熱型バイオセンサーThe biosensor is a device which is used for detecting, recording, and transmitting information related to any physiological changes or the presence of various chemicals or biological materials in the environment. In other words, we can say that it is an analytical device, which converts the biological response into electrical signals. The biosensors technology is now being used for the development …
- コンクリート冷却の世界市場予測(~2026):種類別(水冷、氷冷、風冷、液体窒素冷却)、用途別、地域別The global concrete cooling market was valued at USD 936.0 Million in 2015 and is projected to reach USD 1,722.4 Million by 2026, at a CAGR of 5.7% from 2016 to 2026. This growth is mainly attributed to the increasing demand for concrete cooling systems in Middle East countries and countries across the world that have high temperatures. Concrete cooling is a technique which is used for reducing th …
- PT:医療検査市場2014The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and PT testing specifically, will become more standardized, offering opportu …